Connect Biopharma's stock dropped on Tuesday. What's going on?

Sep 15, 2026, 12:00 PM ETResultsRead the original at benzinga.com

Neutral

The Phase 2 trial missed its primary goal. It showed improved lung function and clean safety, so the result is mixed for Connect Biopharma.

CNTB · Connect Biopharma Holdings Limited

AI read · Neutral

The AI's read

Connect Biopharma released topline Phase 2 results for rademikibart. The trial missed its main endpoint despite a ~66% drop in treatment failures, and it showed a positive lung function secondary plus clean safety. Those facts pull different ways, so I treat the news as neutral for the company.

Get alerts for CNTB

Follow Connect Biopharma Holdings Limited (CNTB) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for CNTB

Free on the App Store and Google Play, or on the web.